Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
59 hedge funds and large institutions have $77.3M invested in Vaxart in 2014 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 22 increasing their positions, 8 reducing their positions, and 3 closing their positions.
567% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 3
236% more capital invested
Capital invested by funds: $23M → $77.3M (+$54.3M)
175% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 8
40% more funds holding
Funds holding: 42 → 59 (+17)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $175K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$13.9M |
| 2 |
HM
HealthCor Management
New York
|
+$6.47M |
| 3 |
BC
Broadfin Capital
New York
|
+$3.58M |
| 4 |
VAM
Visium Asset Management
New York
|
+$3.37M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$2.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
-$1.56M |
| 2 |
TL
TowerView LLC
New York
|
-$815K |
| 3 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
-$422K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$321K |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$134K |
VXRT Hedge Fund Activity: Q1 2014 in Review
59 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q1 2014, worth a combined $77.3M — up 236% from $23M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new VXRT positions and 3 closed out — a net gain of 17 holders — while 22 added to existing stakes and 8 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $13.9M. The largest seller was 683 Capital Management, cutting an estimated $1.56M.
- 59 institutional investors held Vaxart (VXRT) as of Q1 2014, up from 42 in Q4 2013.
- Funds reported $77.3M of Vaxart stock for Q1 2014, up 236% quarter-over-quarter.
- 20 funds opened new Vaxart positions in Q1 2014 and 3 closed out, a net change of +17 holders.
- The largest Vaxart buyer in Q1 2014 was JP Morgan Chase, an estimated $13.9M added.
- The largest Vaxart seller in Q1 2014 was 683 Capital Management, an estimated $1.56M sold.
Based on aggregated 13F filings for Q1 2014.